详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Lu,Shun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] * ; Fang,Jian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Li,Xingya[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Cao,Lejie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhou,Jianying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Guo,Qisen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liang,Zongan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Cheng,Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Jiang,Liyan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Yang,Nong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Han,Zhigang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Shi,Jianhua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Chen,Yuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Xu,Hua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhang,Helong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Zhang,Di[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Li,Jing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Wang,Linfang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Ren,Yongxin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Su,Weiguo[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ;

单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China [2]Peking Univ, Dept Thorac Oncol 2, Canc Hosp & Inst, Beijing, Peoples R China [3]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China [4]First Affiliated Hosp USTC, Anhui Prov Hosp, Hefei, Peoples R China [5]Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China [6]Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China [7]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [8]Jilin Canc Hosp, Changchun, Peoples R China [9]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai, Peoples R China [10]Cent South Univ, Affiliated Canc Hosp, Hunan Canc Hosp, Sch Med, Changsha, Peoples R China [11]Xinjiang Med Univ, Affiliated Canc Hosp, Dept Lung Canc Chemotherapy 1, Urumqi, Peoples R China [12]Linyi Canc Hosp, Linyi, Shandong, Peoples R China [13]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China [14]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China [15]Air Force Med Univ, Tangdu Hosp, Xian, Peoples R China [16]Hutchison MediPharma Ltd, Shanghai, Peoples R China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2018]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China [2]Peking Univ, Dept Thorac Oncol 2, Canc Hosp & Inst, Beijing, Peoples R China [3]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China [4]First Affiliated Hosp USTC, Anhui Prov Hosp, Hefei, Peoples R China [5]Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Peoples R China [6]Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China [7]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [8]Jilin Canc Hosp, Changchun, Peoples R China [9]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai, Peoples R China [10]Cent South Univ, Affiliated Canc Hosp, Hunan Canc Hosp, Sch Med, Changsha, Peoples R China [11]Xinjiang Med Univ, Affiliated Canc Hosp, Dept Lung Canc Chemotherapy 1, Urumqi, Peoples R China [12]Linyi Canc Hosp, Linyi, Shandong, Peoples R China [13]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China [14]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China [15]Air Force Med Univ, Tangdu Hosp, Xian, Peoples R China [16]Hutchison MediPharma Ltd, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Phase II study of savolitinib in patients (pts) with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations (METex14+)

文献详情